Inhibitors of deacetylating enzymes such as HDAC6 and Sirt2 have shown promise in restoring tubulin acetylation, improving axonal transport, and exerting neuroprotective effects in models of AD, PD, and HSP.90 The gene discussed is HDAC6; the disease is Alzheimer disease.